Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-24-029143

Chief Executive Officer sold 2,500 shares at $8.20 ($20,491)

  • Chief Executive Officer acquired 2,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Townsend Richard Nolan · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-10 Exercise or conversion : show line 1 in the form 10b5-1 +2,500 $2.33 $5,825 123,195 D
2024-12-10 Sale : show line 2 in the form 10b5-1 −2,500 $8.20 $20,491 120,695 D
Open-market sales · 2,500 sh · avg $8.20 · $20,491

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-10 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −2,500 118,655 D
Loading xslF345X05/form4-12122024_051206.xml…